Measuring Educational Intervention Impact
GrantID: 11101
Grant Funding Amount Low: $250,000
Deadline: December 5, 2025
Grant Amount High: $400,000
Summary
Explore related grant categories to find additional funding opportunities aligned with this program:
Financial Assistance grants, Health & Medical grants, Opportunity Zone Benefits grants, Other grants, Research & Evaluation grants, Science, Technology Research & Development grants.
Grant Overview
Mitigating Risk in Research & Evaluation Projects Funded by the Developmental Research Grant for Clinical Project The Developmental Research Grant for Clinical Project, offered by a Banking Institution, supports innovative Research & Evaluation projects with funding ranging from $250,000 to $400,000. While the grant encourages groundbreaking research, it is crucial for applicants to understand the risks associated with such projects and how to mitigate them. One concrete regulation that applies to Research & Evaluation projects is the requirement to comply with the National Science Foundation's (NSF) research misconduct policies. The NSF defines research misconduct as fabrication, falsification, or plagiarism in proposing, performing, or reviewing research, or in reporting research results. Applicants must ensure that their projects adhere to these policies to avoid eligibility barriers.## Unique Delivery Challenges in Research & Evaluation Research & Evaluation projects often face unique delivery challenges, such as managing complex data sets and ensuring the reliability of evaluation methods. A verifiable delivery challenge is the need to balance the rigor of evaluation methods with the practical constraints of implementing innovative projects. For instance, projects may need to adapt to changes in participant enrollment or unexpected outcomes, which can impact the validity of the evaluation. To address this challenge, applicants should develop flexible evaluation plans that can accommodate potential changes in project implementation.The Banking Institution's grant program prioritizes projects that demonstrate a clear understanding of potential risks and have strategies in place to mitigate them. Applicants should be aware of the eligibility barriers, such as the requirement to demonstrate a clear potential for significant impact and the need to develop novel technology or tools that can significantly accelerate research. To manage risk, applicants should also be aware of compliance traps, such as failing to adhere to NSF research misconduct policies or not meeting the grant's reporting requirements. The grant requires recipients to report on specific outcomes and KPIs, such as the development of new technologies or tools, and the potential for significant impact on the field. ## Measuring Success in Research & Evaluation Projects The success of Research & Evaluation projects funded by the Developmental Research Grant for Clinical Project is measured by the achievement of specific outcomes and KPIs. Applicants should be aware of the required outcomes, such as the development of novel technology or tools, and the potential for significant impact on the field. The grant also requires recipients to report on their progress and outcomes, including any challenges or risks encountered during the project. To ensure compliance with the grant's requirements, applicants should carefully review the NSF's guidelines for SBIR grants and the Banking Institution's grant program guidelines. Applicants should also be aware of the potential risks associated with SBIR funding, such as the need to demonstrate a clear potential for commercialization or societal impact. Q: How can I ensure that my Research & Evaluation project complies with the NSF's research misconduct policies? A: To ensure compliance, familiarize yourself with the NSF's definition of research misconduct and develop policies and procedures to prevent fabrication, falsification, or plagiarism in your project. Q: What are the most significant risks associated with Research & Evaluation projects funded by the Developmental Research Grant for Clinical Project? A: The most significant risks include failing to demonstrate a clear potential for significant impact, not developing novel technology or tools, and not meeting the grant's reporting requirements. To mitigate these risks, develop a comprehensive project plan and evaluation strategy. Q: How can I demonstrate the potential for significant impact in my Research & Evaluation project? A: To demonstrate potential for significant impact, clearly articulate the project's goals and objectives, and provide a compelling rationale for how the project will achieve significant impact in the field, such as through the development of new treatments for autism or advancements in science and technology research and development.
Eligible Regions
Interests
Eligible Requirements
Related Searches
Related Grants
Grant for Reduction in Dairy and Livestock Sectors
Grant to reduce enteric methane emissions in the dairy and livestock sectors...
TGP Grant ID:
57264
Nonprofit Funding for Global Literacy Demonstration
Grants are awarded on a rolling basis. Check the grant provider's website for application due da...
TGP Grant ID:
44792
Graduate Student Travel Grant for ALANA Researchers
The primary goal of this grant is to remove financial barriers that often hinder underrepresented gr...
TGP Grant ID:
59471
Grant for Reduction in Dairy and Livestock Sectors
Deadline :
Ongoing
Funding Amount:
$0
Grant to reduce enteric methane emissions in the dairy and livestock sectors...
TGP Grant ID:
57264
Nonprofit Funding for Global Literacy Demonstration
Deadline :
2099-12-31
Funding Amount:
$0
Grants are awarded on a rolling basis. Check the grant provider's website for application due dates.Funding For program supports strategic field-b...
TGP Grant ID:
44792
Graduate Student Travel Grant for ALANA Researchers
Deadline :
2023-11-01
Funding Amount:
Open
The primary goal of this grant is to remove financial barriers that often hinder underrepresented graduate students from engaging in valuable research...
TGP Grant ID:
59471